Parkman Healthcare Partners as of June 30, 2024
Portfolio Holdings for Parkman Healthcare Partners
Parkman Healthcare Partners holds 90 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Boston Scientific Corporation (BSX) | 5.7 | $43M | 552k | 77.01 | |
| Insulet Corporation (PODD) | 4.8 | $36M | 179k | 201.80 | |
| United Therapeutics Corporation (UTHR) | 4.8 | $36M | 111k | 318.55 | |
| Eli Lilly & Co. (LLY) | 3.8 | $29M | 32k | 905.38 | |
| Cooper Cos (COO) | 3.6 | $27M | 308k | 87.30 | |
| Tenet Healthcare Corp Com New (THC) | 2.7 | $20M | 149k | 133.03 | |
| Agios Pharmaceuticals (AGIO) | 2.6 | $19M | 446k | 43.12 | |
| Longboard Pharmaceuticals In (LBPH) | 2.5 | $19M | 694k | 27.03 | |
| Rxsight (RXST) | 2.4 | $18M | 297k | 60.17 | |
| Dex (DXCM) | 2.4 | $18M | 157k | 113.38 | |
| Becton, Dickinson and (BDX) | 2.1 | $16M | 68k | 233.71 | |
| Neurocrine Biosciences (NBIX) | 2.1 | $16M | 115k | 137.67 | |
| Anthem (ELV) | 2.0 | $15M | 28k | 541.86 | |
| Schrodinger (SDGR) | 1.9 | $14M | 721k | 19.34 | |
| Intra Cellular Therapies (ITCI) | 1.7 | $13M | 185k | 68.49 | |
| Abbott Laboratories (ABT) | 1.7 | $13M | 122k | 103.91 | |
| Mannkind Corp Com New (MNKD) | 1.7 | $13M | 2.4M | 5.22 | |
| Day One Biopharmaceuticals I (DAWN) | 1.7 | $13M | 909k | 13.78 | |
| Merck & Co Put Option (MRK) | 1.7 | $12M | 100k | 123.80 | |
| Syndax Pharmaceuticals (SNDX) | 1.7 | $12M | 601k | 20.53 | |
| Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA) | 1.6 | $12M | 647k | 18.67 | |
| Icon SHS (ICLR) | 1.6 | $12M | 37k | 313.47 | |
| Vaxcyte (PCVX) | 1.5 | $11M | 150k | 75.51 | |
| Humana (HUM) | 1.5 | $11M | 30k | 373.65 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 1.5 | $11M | 535k | 20.24 | |
| Edgewise Therapeutics (EWTX) | 1.4 | $10M | 575k | 18.01 | |
| Nurix Therapeutics (NRIX) | 1.3 | $9.9M | 475k | 20.87 | |
| Qiagen Nv Shs New (QGEN) | 1.3 | $9.6M | 234k | 41.09 | |
| Inari Medical Ord (NARI) | 1.3 | $9.4M | 196k | 48.15 | |
| Keros Therapeutics (KROS) | 1.2 | $9.1M | 199k | 45.70 | |
| Alphatec Hldgs Com New (ATEC) | 1.2 | $8.9M | 852k | 10.45 | |
| Arcellx Common Stock (ACLX) | 1.2 | $8.7M | 157k | 55.19 | |
| Verona Pharma Sponsored Ads (VRNA) | 1.2 | $8.6M | 595k | 14.46 | |
| Gilead Sciences (GILD) | 1.1 | $8.6M | 125k | 68.61 | |
| AmerisourceBergen (COR) | 1.1 | $8.6M | 38k | 225.30 | |
| Bristol Myers Squibb (BMY) | 1.1 | $8.3M | 200k | 41.53 | |
| Xenon Pharmaceuticals (XENE) | 1.1 | $8.2M | 209k | 38.99 | |
| Travere Therapeutics (TVTX) | 1.1 | $8.0M | 970k | 8.22 | |
| Ionis Pharmaceuticals (IONS) | 1.0 | $7.7M | 162k | 47.66 | |
| Anaptysbio Inc Common (ANAB) | 0.9 | $6.4M | 256k | 25.06 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.8 | $6.3M | 141k | 44.79 | |
| Arcus Biosciences Incorporated (RCUS) | 0.8 | $6.3M | 416k | 15.23 | |
| Haemonetics Corporation (HAE) | 0.8 | $6.3M | 76k | 82.73 | |
| Castle Biosciences (CSTL) | 0.8 | $6.0M | 278k | 21.77 | |
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 0.8 | $5.8M | 354k | 16.25 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 0.8 | $5.7M | 876k | 6.52 | |
| Silence Therapeutics Ads (SLN) | 0.7 | $5.5M | 290k | 19.00 | |
| Insmed Com Par $.01 (INSM) | 0.7 | $5.4M | 80k | 67.00 | |
| CVRX (CVRX) | 0.7 | $5.4M | 448k | 11.99 | |
| Applied Therapeutics (APLT) | 0.7 | $5.4M | 1.1M | 4.67 | |
| Avadel Pharmaceuticals Com Shs (AVDL) | 0.7 | $5.3M | 378k | 14.06 | |
| Sutro Biopharma (STRO) | 0.7 | $5.3M | 1.8M | 2.93 | |
| Amicus Therapeutics (FOLD) | 0.7 | $5.0M | 503k | 9.92 | |
| Replimune Group (REPL) | 0.6 | $4.7M | 525k | 9.00 | |
| Performant Finl (PFMT) | 0.6 | $4.7M | 1.6M | 2.90 | |
| Livanova SHS (LIVN) | 0.6 | $4.7M | 85k | 54.82 | |
| Urogen Pharma (URGN) | 0.6 | $4.6M | 275k | 16.78 | |
| Veracyte (VCYT) | 0.6 | $4.5M | 210k | 21.67 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.6 | $4.5M | 101k | 43.97 | |
| Peregrine Pharmaceuticals (CDMO) | 0.6 | $4.4M | 621k | 7.14 | |
| Ultragenyx Pharmaceutical (RARE) | 0.6 | $4.1M | 100k | 41.10 | |
| Fortrea Hldgs Common Stock (FTRE) | 0.5 | $3.6M | 153k | 23.34 | |
| Arvinas Ord (ARVN) | 0.4 | $3.3M | 125k | 26.62 | |
| Nuvalent Inc-a (NUVL) | 0.4 | $3.3M | 43k | 75.86 | |
| Tg Therapeutics (TGTX) | 0.4 | $3.2M | 180k | 17.79 | |
| Ventyx Biosciences (VTYX) | 0.4 | $2.7M | 1.2M | 2.31 | |
| Merus N V (MRUS) | 0.4 | $2.7M | 45k | 59.17 | |
| Terns Pharmaceuticals (TERN) | 0.4 | $2.7M | 390k | 6.81 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.3 | $2.6M | 135k | 19.21 | |
| Esperion Therapeutics (ESPR) | 0.3 | $2.5M | 1.1M | 2.22 | |
| BioCryst Pharmaceuticals (BCRX) | 0.3 | $2.5M | 400k | 6.18 | |
| Dynavax Technologies Corp Com New (DVAX) | 0.3 | $2.4M | 217k | 11.23 | |
| Quanterix Ord (QTRX) | 0.3 | $2.3M | 176k | 13.21 | |
| Si-bone (SIBN) | 0.3 | $2.0M | 153k | 12.93 | |
| Elanco Animal Health (ELAN) | 0.2 | $1.8M | 126k | 14.43 | |
| Third Harmonic Bio (THRD) | 0.2 | $1.7M | 133k | 13.00 | |
| Annexon (ANNX) | 0.2 | $1.6M | 327k | 4.90 | |
| Essa Pharma Com New (EPIX) | 0.2 | $1.3M | 252k | 5.26 | |
| Ardelyx (ARDX) | 0.1 | $1.1M | 150k | 7.41 | |
| Viking Therapeutics (VKTX) | 0.1 | $1.1M | 20k | 53.01 | |
| Akoya Biosciences (AKYA) | 0.1 | $879k | 376k | 2.34 | |
| Eton Pharmaceuticals (ETON) | 0.1 | $833k | 253k | 3.29 | |
| Entera Bio SHS (ENTX) | 0.1 | $739k | 402k | 1.84 | |
| Vyne Therapeutics (VYNE) | 0.1 | $680k | 345k | 1.97 | |
| Reviva Pharmaceutcls Hldgs I (RVPH) | 0.1 | $646k | 505k | 1.28 | |
| Augmedix (AUGX) | 0.1 | $499k | 567k | 0.88 | |
| X4 Pharmaceuticals (XFOR) | 0.1 | $468k | 807k | 0.58 | |
| Tela Bio (TELA) | 0.1 | $460k | 98k | 4.70 | |
| Alpha Teknova (TKNO) | 0.1 | $406k | 297k | 1.37 | |
| Xeris Pharmaceuticals (XERS) | 0.0 | $227k | 101k | 2.25 |
